Back to search

Article

The Cystic Fibrosis treatment, Trikafta, affects growth, viability, and cell wall of <i>Aspergillus fumigatus</i> biofilms

2023-06-21

Abstract excerpt

<h4>ABSTRACT</h4> People with Cystic Fibrosis (pwCF) commonly test positive for the pathogenic fungus, Aspergillus fumigatus, which is associated with a decline in lung function. Trikafta is a recently approved therapy for pwCF that improves quantity and function of the CFTR protein, however, it is not known how Trikafta affects microbial communities in the lung. Therefore, the aim of this study was to determine...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fbda5923-064e-5560-8488-964917ab3fb6
DOI
10.1101/2023.06.20.545692
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Cystic Fibrosis treatment, Trikafta, affects growth, viability, and cell wall of <i>Aspergillus fumigatus</i> biofilmsDOI 10.1101/2023.06.20.545692
Select a neighboring publication to make it the new centre.